The study was supported by research grants from the Roche Organ Transplant Research Foundation (ROTRF) and Astellas. Markus Selzner was supported by an ASTS Career Development Award. Matthias Knaak was supported by the Astellas Research Scholarship. We thank Uwe Mummenhoff and the Birmingham family for their generous support.

<ol>
	<li>Mehrabi, A., Fonouni, H., Muller, S. A., Schmidt, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Current+concepts+in+transplant+surgery:+liver+transplantation+today.">Current concepts in transplant surgery: liver transplantation today.</a> Langenbecks Arch. Surg. 393 (3), 245-260 (2008).</li><li>Qiu, J., Ozawa, M., Terasaki, P. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Liver+transplantation+in+the+United+States.">Liver transplantation in the United States.</a> Clin. Transpl. , 17-28 (2005).</li><li>Chalstrey, L. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Technique+of+orthotopic+liver+transplantation+in+the+pig.">Technique of orthotopic liver transplantation in the pig.</a> Br. J. Surg. 58 (3), 585-588 (1971).</li><li>Esmaeilzadeh, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Technical+guidelines+for+porcine+liver+allo-transplantation:+a+review+of+literature.">Technical guidelines for porcine liver allo-transplantation: a review of literature.</a> Ann. Transplant. 17 (2), 101-110 (2012).</li><li>Calne, R. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Observations+of+orthotopic+liver+transplantation+in+the+pig.">Observations of orthotopic liver transplantation in the pig.</a> Br. Med. J. 2 (5550), 478-480 (1967).</li><li>Memsic, L., Quinones-Baldrich, W., Kaufman, R., Rasool, I., Busuttil, R. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+comparison+of+porcine+orthotopic+liver+transplantation+using+a+venous-venous+bypass+with+and+without+a+nonpulsatile+perfusion+pump.">A comparison of porcine orthotopic liver transplantation using a venous-venous bypass with and without a nonpulsatile perfusion pump.</a> J. Surg. Res. 41, 33-40 (1986).</li><li>Torres, O. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hemodynamic+alterations+during+orthotopic+liver+experimental+transplantation+in+pigs.">Hemodynamic alterations during orthotopic liver experimental transplantation in pigs.</a> Acta. Cir. Bras. 23 (2), 135-139 (2008).</li><li>Battersby, C., Hickman, R., Saunders, S. J., Terblanche, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Liver+function+in+the+pig.+1.+The+effects+of+30+minutes'+normothermic+ischaemia.">Liver function in the pig. 1. The effects of 30 minutes' normothermic ischaemia.</a> Br. J. Surg. 61 (1), 27-32 (1974).</li><li>Smith, A. C., Swindle, M. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Preparation+of+swine+for+the+laboratory.">Preparation of swine for the laboratory.</a> Ilar. J. 47 (4), 358-363 (2006).</li><li>Swindle, M. M., Smith, A. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Best+practices+for+performing+experimental+surgery+in+swine.">Best practices for performing experimental surgery in swine.</a> J. Invest. Surg. 26 (2), 63-71 (2013).</li><li>Moench, C., Moench, K., Lohse, A. W., Thies, J., Otto, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prevention+of+ischemic-type+biliary+lesions+by+arterial+back-table+pressure+perfusion.">Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion.</a> Liver Transpl. 9 (3), 285-289 (2003).</li><li>Koski, E. M., Suhonen, M., Mattila, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ultrasound-facilitated+central+venous+cannulation.">Ultrasound-facilitated central venous cannulation.</a> Crit. Care Med. 20 (3), 424-426 (1992).</li><li>Lange, J. J., Hoitsma, H. F., Meijer, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Anaesthetic+management+in+experimental+orthotopic+liver+transplantation+in+the+pig.">Anaesthetic management in experimental orthotopic liver transplantation in the pig.</a> Eur. Surg. Res. 16 (6), 360-365 (1984).</li><li>Kaiser, G. M., Heuer, M. M., Fruhauf, N. R., Kuhne, C. A., Broelsch, C. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=General+handling+and+anesthesia+for+experimental+surgery+in+pigs.">General handling and anesthesia for experimental surgery in pigs.</a> J. Surg. Res. 130 (1), 73-79 (2006).</li><li>Heuer, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Liver+transplantation+in+swine+without+venovenous+bypass.">Liver transplantation in swine without venovenous bypass.</a> Eur. Surg. Res. 45 (1), 20-25 (2010).</li><li>Gruttadauria, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Porcine+orthotopic+liver+autotransplantation:+facilitated+technique.">Porcine orthotopic liver autotransplantation: facilitated technique.</a> J. Invest. Surg. 14 (2), 79-82 (2001).</li><li>Falcini, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Veno-venous+bypass+in+experimental+liver+transplantation:+portal-jugular+versus+caval-portal-jugular.">Veno-venous bypass in experimental liver transplantation: portal-jugular versus caval-portal-jugular.</a> G. Chir. 11 (4), 206-210 (1990).</li><li>Filipponi, F., Benassai, C., Falcini, F., Martini, E., Cataliotti, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biliary+tract+complications+in+orthotopic+liver+transplantation:+an+experimental+study+in+the+pig.">Biliary tract complications in orthotopic liver transplantation: an experimental study in the pig.</a> Ital. J. Surg. Sci. 19 (2), 131-136 (1989).</li><li>Terblanche, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Orthotopic+liver+homotransplantation:+an+experimental+study+in+the+unmodified+pig.">Orthotopic liver homotransplantation: an experimental study in the unmodified pig.</a> S. Afr. Med. J. 42 (20), 486-497 (1968).</li><li>Calne, R. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prolonged+survival+of+liver+transplants+in+the+pig.">Prolonged survival of liver transplants in the pig.</a> Br. Med. J. 4 (5580), 645-648 (1967).</li><li>Battersby, C., Egerton, W. S., Balderson, G., Kerr, J. F., Burnett, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Another+look+at+rejection+in+pig+liver+homografts.">Another look at rejection in pig liver homografts.</a> Surgery. 76 (4), 617-623 (1974).</li><li>Net, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+effect+of+normothermic+recirculation+is+mediated+by+ischemic+preconditioning+in+NHBD+liver+transplantation.">The effect of normothermic recirculation is mediated by ischemic preconditioning in NHBD liver transplantation.</a> Am. J. Transplant. 5 (10), 2385-2392 (2005).</li><li>Guarrera, J. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hypothermic+machine+perfusion+of+liver+grafts+for+transplantation:+technical+development+in+human+discard+and+miniature+swine+models.">Hypothermic machine perfusion of liver grafts for transplantation: technical development in human discard and miniature swine models.</a> Transplant Proc. 37 (1), 323-325 (2005).</li><li>Minor, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hypothermic+reconditioning+by+gaseous+oxygen+improves+survival+after+liver+transplantation+in+the+pig.">Hypothermic reconditioning by gaseous oxygen improves survival after liver transplantation in the pig.</a> Am. J. Transplant. 11 (12), 2627-2634 (2011).</li><li>Kelly, D. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Porcine+partial+liver+transplantation:+a+novel+model+of+the+'small-for-size'+liver+graft.">Porcine partial liver transplantation: a novel model of the 'small-for-size' liver graft.</a> Liver Transpl. 10 (2), 253-263 (2004).</li><li>Meijer, S., Hoitsma, H. F., Visser, J. J., de Lange, J. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Long+term+survival+following+orthotopic+liver+transplantation+in+pigs;+with+special+reference+to+gastric+ulcer+complications.">Long term survival following orthotopic liver transplantation in pigs; with special reference to gastric ulcer complications.</a> Neth. J. Surg. 36 (6), 168-171 (1984).</li></ol>

The authors have nothing to disclose.

Experimental porcino OLTx es un procedimiento difícil para un contexto de investigación sin los recursos de cuidados intensivos de un escenario clínico. Las posibles complicaciones incluyen la inestabilidad hemodinámica, hemorragia, isquemia de órganos, la hipotermia y metabólica, así como respiratoria, descompensación. Para cualquier grupo de investigación, formación suficiente procesal de la técnica quirúrgica 5, así como el 14,15 anestesia cerdo es obligatoria con el fin de lograr resultados representativos y reproducibles. Muchas sutilezas técnicas se han descrito en la literatura, especialmente en relación con la fase de reconstrucción vascular 5. El protocolo OLTx descrito anteriormente proporciona la información necesaria para un modelo de cava-sustitución parecido OLTx humano. Los resultados proporcionados demuestran supervivencia de los animales fiable y recuperación del injerto en ambos modelos HBD y DCD. El protocolo es aplicable en situaciones de supervivencia a corto plazo utilizados en la reperfusión del injerto experimentos, por ejemplo, así como en modelos de supervivencia a largo plazo, tales como estudios de tolerancia. Un gran obstáculo de porcino OLTx es la relativamente pobre tolerancia de cava y vena porta pinzamiento. Congestión esplácnica durante la fase anhepática causa la hipertensión venosa y daño capilar que puede conducir a mayor isquemia intestinal y la inestabilidad hemodinámica hasta el punto de un choque irreversible, incluso después de la reperfusión de órganos 7. Desde la vena cava está completamente integrado en el parénquima hepático, un procedimiento de lengüeta de la cava de preservación no es factible. La oclusión total de la vena cava durante la fase de reconstrucción cava perjudica la estabilidad hemodinámica del cerdo. Aunque algunos informes muestran que porcino OLTx puede llevarse a cabo durante cava y la vena portal oclusión total de menos de 25 min 16,17, una técnica de derivación porto-cava-yugular para el momento de la reconstrucción vascular es la opción más segura y más práctico 7- 9,18. En ªexperiencia e autores, un pasivo de derivación porto-yugular no es óptima para mantener el hemodinámicamente estable cerdo durante la fase anhepática. El modelo de derivación, incluyendo la descompresión activa de tanto cava infrahepática y la vena porta, permite una fase de reconstrucción calma de las anastomosis cava y portal suprahepáticas incluso con el tiempo de sujeción prolongada debido a complicaciones imprevistas. Contrariamente a los informes anteriores 7, una esplenectomía no es obligatoria cuando se retira el catéter de derivación portal. Tanto la arteria esplénica y la vena se cierran a medio camino a lo largo de la longitud del bazo dejando la mitad proximal suficientemente perfundido. Las complicaciones como sangrado o embolia gaseosa debido a la desconexión de derivación son evitables, asegurando que la derivación se coloca con cuidado y bien sujeto. En supervivencia a largo plazo OLTx experimentos, la anastomosis de las vías biliares se considera un punto débil debido a su alta tasa de complicaciones 19. El tejido biliar es muy frágil y needs especial cuidado cuando se maneja. Muchas técnicas de anastomosis diferentes han sido descritos 5,19. Una anastomosis de extremo a extremo es técnicamente fácil y asociado con mínimas complicaciones 19. Una sutura continua con una aguja no cortante incluyendo grandes secciones de tejido conectivo peribiliary parece ser superior a una sutura interrumpida. El conducto biliar se coloca bajo tensión innecesaria cuando se anudan los puntos individuales de la sutura interrumpida. Esto puede resultar en lágrimas de tejido y fugas biliares consecutivos. El material de sutura - absorbible o no absorbible - no suele ser importante, dada su limitada vida útil hasta que se termina el cerdo. Para los modelos de supervivencia a largo plazo durante varios meses, las suturas absorbibles - como en OLTx humana - son preferibles. Cuidados específicos se debe tomar con el post-operatorio de seguimiento. Nutrición suficiente y suministro de fluido, un protocolo de alivio del dolor fiable, y una inmunosupresión adecuadarégimen son obligatorios. Para los experimentos a largo plazo, la inmunosupresión parece particularmente importante. En comparación con otros mamíferos, cerdos muestran una tasa de rechazo inmunológico sorprendentemente baja después OLTx 20,21. Infiltraciones de células redondas son máximas durante la segunda semana después del trasplante y disminuyen espontáneamente, incluso sin inmunosupresión. El rechazo es raramente la causa de muerte después de porcino OLTx 22. Sin embargo, incluso con el protocolo de inmunosupresión que implica la administración iv y esteroides inhibidores de la calcineurina po mencionado aquí, rechazo de injerto se indica mediante un leve aumento de las transaminasas partir de alrededor de 4 días después de OLTx y confirmado por campo aparente portal infiltración de células redondas. Inhibidores de la calcineurina se puede dar ya sea po 23,24 o 25,26 iv; Ambos métodos tienen desventajas. Incluso con SIDA aplicación oral, la cantidad real de alcanzar el tracto gastro-intestinal sigue siendo difícil de alcanzar. Por otra parte, la infusión iv continua enla pluma de un cerdo con un animal activo es difícil. Por lo tanto, la aplicación iv debe ser realizado como un bolo, que se traduce en picos de alta concentración de fármaco junto con los efectos tóxicos potenciales. Sin embargo, ambos métodos de aplicación parecen permitir la supervivencia a largo plazo. Similar a un entorno clínico, se recomienda la profilaxis de la úlcera de estrés post-operatorio. Hemorragia postoperatoria de las úlceras pépticas es un problema frecuente y puede estar relacionado con una función hepática 27. Después de algunos casos de sangrado gastrointestinal en ambos grupos OLTx, los autores comenzaron la profilaxis regulares con pantoprazol y no experimentaron ningún sangrado gastrointestinal desde entonces. El mantenimiento estricto de condiciones estériles intraoperatorio, comparables a las condiciones en un quirófano clínica y profilaxis antibiótica consiguientes, disminuye el riesgo de complicaciones infecciosas. En conclusión, este artículo provides información práctica para el establecimiento de un programa OLTx porcina en un contexto de investigación. Dedicación suficiente, la práctica y el trabajo en equipo es importante para disminuir el período de aprendizaje, para producir resultados fiables, y para reducir los costos y el número de animales de investigación.

El trasplante hepático ortotópico (OLTx) es la única opción de tratamiento para los pacientes con enfermedad hepática terminal o carcinoma hepatocelular avanzado. Durante los últimos 25 años, el número de candidatos en la lista de espera ha aumentado gradualmente y ahora supera con creces el número de injertos disponibles. En la mayoría de las regiones de trasplante, del 20 al 30% de los pacientes en lista de espera para un trasplante de hígado mueren sin recibir un trasplante de órganos o se retirado de la lista debido a la progresión de la enfermedad. Estrategias para aumentar el número de donantes y, por lo tanto, el número de injertos disponibles, se requiere desesperadamente. Criterios ampliados de asignación de órganos, de conservación prolongada del injerto, y de inducción de tolerancia inmunológica aún representan grandes desafíos clínicos 1-3. Por lo tanto, la investigación experimental OLTx es fundamental con el fin de optimizar la práctica OLTx clínica. Porcino OLTx es un modelo experimental bien establecida que se asemeja OLTx humana en muchas maneras, incluyendo ltamaño iver, anatomía y fisiología 4-6. Así, se ha convertido en un método experimental estándar en los campos de investigación, tales como las técnicas quirúrgicas, la fisiología, la inmunología, la preservación y la lesión por isquemia-reperfusión. Numerosas técnicas de adquisición de injerto, hepatectomía receptor, y, en particular, la reconstrucción vascular, se han descrito en la literatura 5. La elección de la técnica adecuada varía de acuerdo a la preferencia del investigador y capacidad técnica. En contraste con el escenario humano, congestión esplácnica durante la fase de anhepática representa un problema importante en porcino OLTx. Isquemia intestinal y subsiguiente daño vascular congestiva pueden causar inestabilidad hemodinámica severa, poniendo en peligro la supervivencia de cerdo y, por lo tanto, el éxito del experimento 7-9. Por lo tanto, suficiente descompresión intestinal es obligatoria, especialmente en entornos experimentales técnicamente menos refinados. Nosotrosing un shunt porto-cava-yugular activo para la duración de la fase anhepática es una opción fiable para evitar la congestión intestinal. El sistema puede ser utilizado para los experimentos de reperfusión temprana, así como escenarios de supervivencia a largo plazo. El siguiente protocolo contiene toda la información para un modelo de trasplante hepático estable y reproducible en los cerdos, incluyendo la contratación de hígado de donante, operación destinatario incluyendo hepatectomía y técnicas de reconstrucción recipiente de extremo a extremo, y el cuidado postoperatorio.

<table border="0" cellpadding="0" cellspacing="0">
	<tbody>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Atropine Sulphate 15mg/30mL</td>
			<td style="width:257px;">Rafter 8 Products</td>
			<td align="right" style="width:201px;">238481</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Buprenorphine 0.3mg/mL</td>
			<td style="width:257px;">RB Pharmaceuticals LDT</td>
			<td style="width:201px;">N/A</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Cefazolin 1g</td>
			<td style="width:257px;">Pharmaceutical Partners of Canada Inc.</td>
			<td align="right" style="width:201px;">2237138</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Cyclosporin Oral Solution 5000mg/50mL</td>
			<td style="width:257px;">Novartis Pharmaceuticals Canada Inc.</td>
			<td align="right" style="width:201px;">2150697</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Fentanyl Citrate 0.25mg/5mL</td>
			<td style="width:257px;">Sandoz Canada Inc.</td>
			<td align="right" style="width:201px;">2240434</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Heparin 10,000iU/10mL</td>
			<td style="width:257px;">Leo Pharma A/S</td>
			<td align="right" style="width:201px;">453811</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Isoflurane 99.9%, 250mL</td>
			<td style="width:257px;">Pharmaceutical Partners of Canada Inc.</td>
			<td align="right" style="width:201px;">2231929</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Ketamine Hydrochloride&#160; 5000mg/50mL</td>
			<td style="width:257px;">Bimeda-MTC Animal Health Inc.</td>
			<td align="right" style="width:201px;">612316</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Lactated Ringer&#8217;s + 5% Dextrose, 0.5L</td>
			<td style="width:257px;">Baxter Corporation</td>
			<td align="right" style="width:201px;">61131</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Lacteted Ringer&#8217;s, 1L</td>
			<td style="width:257px;">Baxter Corporation</td>
			<td align="right" style="width:201px;">61085</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Metronidazole 500mg/100mL</td>
			<td style="width:257px;">Baxter Corporation</td>
			<td align="right" style="width:201px;">870420</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Midazolame 50mg/10mL</td>
			<td style="width:257px;">Pharmaceutical Partners of Canada Inc.</td>
			<td align="right" style="width:201px;">2242905</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Pantoprazole 40mg</td>
			<td style="width:257px;">Sandoz Canada Inc.</td>
			<td align="right" style="width:201px;">2306727</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Potassium Chloride 40mEq/20mL</td>
			<td style="width:257px;">Hospira Healthcare Corporation</td>
			<td align="right" style="width:201px;">37869</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Propofol 1000mg/100mL</td>
			<td style="width:257px;">Pharmascience Inc.</td>
			<td align="right" style="width:201px;">2244379</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Protamine Sulfate 50mg/5mL</td>
			<td style="width:257px;">Pharmaceutical Partners of Canada Inc.</td>
			<td align="right" style="width:201px;">2139537</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Saline 0.9%, 1L</td>
			<td style="width:257px;">Baxter Corporation</td>
			<td align="right" style="width:201px;">60208</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Sodium Bicarbonate 50 mEq/50mL</td>
			<td style="width:257px;">Hospira Healthcare Corporation</td>
			<td align="right" style="width:201px;">261998</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Solu-Medrol 500mg</td>
			<td style="width:257px;">Pfizer Canada Inc.</td>
			<td align="right" style="width:201px;">2367963</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Tranexamic Acid 1000mg/10mL</td>
			<td style="width:257px;">Pfizer Canada Inc.</td>
			<td align="right" style="width:201px;">2064413</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">University of Wisconsin Solution, SPS-1</td>
			<td style="width:257px;">Organ Recovery Systms</td>
			<td style="width:201px;">SPS-1</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Xylocaine Endotracheal 10mg/50mL</td>
			<td style="width:257px;">AstraZeneca</td>
			<td align="right" style="width:201px;">2003767</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;"></td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Appose ULC 35W skin stapler</td>
			<td style="width:257px;">Covidien Canada</td>
			<td align="right" style="width:201px;">803712</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Maxon, 1</td>
			<td style="width:257px;">Covidien Canada</td>
			<td align="right" style="width:201px;">606173</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Sofsilk, 0</td>
			<td style="width:257px;">Covidien Canada</td>
			<td style="width:201px;">S606</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Sofsilk, 2-0</td>
			<td style="width:257px;">Covidien Canada</td>
			<td style="width:201px;">S405</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Sofsilk, 3-0</td>
			<td style="width:257px;">Covidien Canada</td>
			<td style="width:201px;">S404</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Surgipro II, 4-0</td>
			<td style="width:257px;">Covidien Canada</td>
			<td style="width:201px;">VP581X</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Surgipro II, 5-0</td>
			<td style="width:257px;">Covidien Canada</td>
			<td style="width:201px;">VP725X</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Surgipro II, 6-0</td>
			<td style="width:257px;">Covidien Canada</td>
			<td style="width:201px;">VP733X</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;"></td>
			<td style="width:257px;"></td>
			<td style="width:201px;"></td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Catheter i.v, 18 G</td>
			<td style="width:257px;">BD Canada</td>
			<td align="right" style="width:201px;">381147</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Cook TPN catheter, 9.5Fr</td>
			<td style="width:257px;">Cook Medical Company</td>
			<td style="width:201px;">C-TPNS-9.5-90</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">PSI Kit for sheath catheter, 8.5Fr</td>
			<td style="width:257px;">Arrow International</td>
			<td style="width:201px;">ASK-09803-UHN</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;"></td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Infusion Pump Line</td>
			<td style="width:257px;">Smith Medical ASD Inc.</td>
			<td style="width:201px;">21-0442-25</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Liver Admin Set (flush line)</td>
			<td style="width:257px;">CardioMed Supplies Inc</td>
			<td align="right" style="width:201px;">17175</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Mallinckrodt, Tracheal Tube, 6.5mm</td>
			<td style="width:257px;">Covidien Canada</td>
			<td align="right" style="width:201px;">86449</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Med-Rx Suction Connecting Tube</td>
			<td style="width:257px;">Benlan Inc.</td>
			<td style="width:201px;">70-8120</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Organ Bag</td>
			<td style="width:257px;">CardioMed Supplies Inc</td>
			<td align="right" style="width:201px;">2990</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Suction Tip</td>
			<td style="width:257px;">Tyco Healthcare Group LP</td>
			<td align="right" style="width:201px;">8888501023</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Valleylab, Cautery Pencil</td>
			<td style="width:257px;">Covidien Canada</td>
			<td style="width:201px;">E2515H</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Valleylab, Patient Return Electrode</td>
			<td style="width:257px;">Covidien Canada</td>
			<td style="width:201px;">E7507</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;"></td>
			<td style="width:257px;"></td>
			<td style="width:201px;"></td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Bypass Connector 3/8&#8221; x 1/4&#8220;</td>
			<td style="width:257px;">Raumedic AG</td>
			<td style="width:201px;">955083-001</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Bypass Connector 3/8&#8221; x 3/8&#8221; Luer Lock</td>
			<td style="width:257px;">Raumedic AG</td>
			<td style="width:201px;">955163-001</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Bypass Connector Y 3/8&#8221; x 3/8&#8221; x 1/4&#8221;</td>
			<td style="width:257px;">Raumedic AG</td>
			<td style="width:201px;">961360-002</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Bypass Tubing 1/4&#8221; x 1/16&#8221;</td>
			<td style="width:257px;">Raumedic AG</td>
			<td style="width:201px;">039505-010</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Bypass Tubing 3/8&#8221; x 3/32&#8221;</td>
			<td style="width:257px;">Raumedic AG</td>
			<td style="width:201px;">039535-005</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Rotaflow Cenrtifugal Pump</td>
			<td style="width:257px;">Maquet-Dynamed</td>
			<td style="width:201px;">HC 2821</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Stainless Steel Hose Clamp Ring, 5mm</td>
			<td style="width:257px;">Oetiker</td>
			<td align="right" style="width:201px;">16700007</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;"></td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Abdominal Retractor</td>
			<td style="width:257px;">Medite GmbH</td>
			<td style="width:201px;">N/A</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">De Bakey &#8211; Beck, Infrahepatic Cava Clamp</td>
			<td style="width:257px;">Aesculap Inc.</td>
			<td style="width:201px;">FB519R</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Diethrich, Atraumaitc Clamp (Portal Vein)</td>
			<td style="width:257px;">Aesculap Inc.</td>
			<td style="width:201px;">FB525R</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Gregory Bull Dog Clamp, curved</td>
			<td style="width:257px;">Aesculap Inc.</td>
			<td style="width:201px;">FB382R</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Gregory Bull Dog Clamp, straight</td>
			<td style="width:257px;">Aesculap Inc.</td>
			<td style="width:201px;">FB381R</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Potts &#8211; De Martel, Scissors</td>
			<td style="width:257px;">Aesculap Inc.</td>
			<td style="width:201px;">BC648R</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Satinsky, Suprahepatic Cava Clamp</td>
			<td style="width:257px;">Aesculap Inc.</td>
			<td style="width:201px;">FB605R</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:276px;">Symetrical Tubing Clamp</td>
			<td style="width:257px;">Codman Instruments</td>
			<td align="right" style="width:201px;">198010</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;"></td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Anesthesia Machine, Optimax</td>
			<td style="width:257px;">Moduflex Anesthesia Equipment</td>
			<td style="width:201px;">SN5180</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Bypass Flow meter, HT 110</td>
			<td style="width:257px;">Transonic Systems Inc.</td>
			<td style="width:201px;">HT110B11106</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Flow meter probe, H6XL</td>
			<td style="width:257px;">Transonic Systems Inc.</td>
			<td style="width:201px;">H6Xl689</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Heat Therapy Pump, T/Pump</td>
			<td style="width:257px;">Gaymar Industries Inc</td>
			<td style="width:201px;">TP500-G89D19</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Infusion Pump 3000</td>
			<td style="width:257px;">SIMS Graseby LTD.</td>
			<td style="width:201px;">SN300050447</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Isoflurane Vapor 19.1</td>
			<td style="width:257px;">Draeger Medical Canada Inc.</td>
			<td style="width:201px;">N/A</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Monitor, Datex AS 3</td>
			<td style="width:257px;">Instrumentarium Corp./ Hitachi</td>
			<td style="width:201px;">D-VHC14-23-02</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Rotaflow Centrifugal Drive Unit</td>
			<td style="width:257px;">Marquet-Dynamed</td>
			<td align="right" style="width:201px;">952301</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Rotaflow Console</td>
			<td style="width:257px;">Marquet-Dynamed</td>
			<td align="right" style="width:201px;">706035</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Temperature Therapy Pad</td>
			<td style="width:257px;">Gaymar Industries Inc</td>
			<td style="width:201px;">TP26E</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Valleylab Force Tx</td>
			<td style="width:257px;">Valleylab Inc.</td>
			<td align="right" style="width:201px;">216151480</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Ventilator, AV 800</td>
			<td style="width:257px;">DRE Medical Equipment</td>
			<td style="width:201px;">40800AVV</td>
			<td style="width:240px;"></td>
		</tr>
		<tr height="19">
			<td height="19" style="height:19px;width:276px;">Warm Touch, Patient Warming System</td>
			<td style="width:257px;">Nellcor/ Covidien Canada</td>
			<td style="width:201px;">5015300A</td>
			<td style="width:240px;"></td>
		</tr>
	</tbody>
</table>

technique of porcine liver procurement and orthotopic transplantation using an active porto-caval shunt

The success of liver transplantation has resulted in a dramatic organ shortage. Each year, a considerable number of patients on the liver transplantation waiting list die without receiving an organ transplant or are delisted due to disease progression. Even after a successful transplantation, rejection and side effects of immunosuppression remain major concerns for graft survival and patient morbidity. 
Experimental animal research has been essential to the success of liver transplantation and still plays a pivotal role in the development of clinical transplantation practice. In particular, the porcine orthotopic liver transplantation model (OLTx) is optimal for clinically oriented research for its close resemblance to human size, anatomy, and physiology. 
Decompression of intestinal congestion during the anhepatic phase of porcine OLTx is important to guarantee reliable animal survival. The use of an active porto-caval-jugular shunt achieves excellent intestinal decompression. The system can be used for short-term as well as long-term survival experiments. The following protocol contains all technical information for a stable and reproducible liver transplantation model in pigs including post-operative animal care.

En un primer estudio trasplante, un modelo de donante corazón latiente (HBD, n = 5) se comparó con un modelo de DCD (n = 10) expuestos a 45 min de isquemia caliente in situ. En ambos grupos, los injertos se conservaron en hielo durante 10 horas después de la contratación. En el grupo de HBD, 100% de los cerdos receptores sobrevivió hasta el final del seguimiento de 5 días después del trasplante. En el grupo de DCD, sólo el 50% de los cerdos receptores sobrevivió durante 5 días debido a problemas de coagulación o descompensación metabólica, como resultado de la función hepática post-operatorio disminuido. Todas las muestras de sangre fueron recolectadas desde el catéter venoso central. Después de la centrifugación, se obtuvieron muestras de suero y se analizaron para la lesión hepatocelular (aspartato aminotransferasa, AST), la función biliar (bilirrubina y fosfatasa alcalina total de), y la función hepática (INR). El curso de tiempo de cada marcador se muestra en las Figuras 2 - 5. <p class="jove_content"Niveles&gt; AST alcanzaron un pico después de 24 horas (1.414 ± 538 U / L en el grupo HBD y 2.296 ± 1.313 U / L en el grupo de DCD, p = 0,13) y volvieron a los valores casi normales después de 5 días. Del mismo modo, los valores de fosfatasa alcalina se incrementaron notablemente después de 36 horas en el grupo de DCD (224 ± 111 U / L) cuando se compara con el grupo de HBD (162 ± 54 U / L, p = 0,27). Si bien la bilirrubina total se mantuvo estable en el grupo HBD (≤ 10 mmol L / largo), se incrementó gradualmente en el grupo DCD hasta el día 5 (23 ± 31 mmol / L, p = 0,43). La gran desviación estándar en los valores de bilirrubina en el grupo de DCD muestra una heterogeneidad lesión biliar peculiar en este grupo. INR como un marcador de la función hepática mostró una tendencia similar a los valores de AST. Valores alcanzó un máximo de 24 horas y fueron restaurados a los valores casi normales después de 5 días. El grupo HBD tenía valores más bajos con un pico a 1,47 ± 0,34 en comparación con el grupo de DCD (pico 1,70 ± 0,36, p = 0,32). Figura 1. Esquema de la derivación porto-cava-yugular. El bypass es llenado con solución de Ringer lactato. A continuación, la parte de la vena cava se sujeta con una abrazadera de tubo, las partes yugular y esplénicas están conectados a los catéteres pre-establecidos, la derivación se abre, y la bomba centrífuga se inicia después del pinzamiento venosa portal. Después de la resección hepática, la parte de la cava de la derivación se inserta y se fija en el infrahepática muñón de la vena cava, craneal a las venas renales. La abrazadera de tubo se libera para permitir la descompresión de la vena cava, además de la descompresión portal. <img alt="Figura 2" src="/files/ftp_upload/52055/52055fig2.jpg" /> Figura 2. aspartato aminotransferasa (AST) (HBD n = 5, DCD n = 10). AST es un marcador sensible de daño hepatocelular. La popa picoer 24 horas es menor en el HBD que en el grupo DCD, lo que sugiere la lesión por reperfusión menos hepática; la desviación estándar más pequeña muestra resultados más homogéneas en el grupo de HBD. <img alt="Figura 3" src="/files/ftp_upload/52055/52055fig3.jpg" /> Figura 3. La bilirrubina total (HBD n = 5, DCD n = 10). Bilirrubina total, como un marcador de eliminación biliar y la bilis integridad de ductos, muestra una tendencia estable y homogéneo con valores por debajo de 10 mmol / L en el grupo de HBD. La curva de la bilirrubina en el grupo de DCD aumenta gradualmente con el tiempo y muestra una desviación estándar alta, lo que sugiere una lesión biliar en sólo una parte del grupo experimental. <img alt="Figura 4" src="/files/ftp_upload/52055/52055fig4.jpg" /> Figura 4. La fosfatasa alcalina (HBD n = 5, n = 10 DCD). La fosfatasa alcalina is un indicador de lesión biliar. Los valores para el grupo de HBD son más bajas que la del grupo de DCD, lo que implica menos lesión biliar. <img alt="Figura 5" src="/files/ftp_upload/52055/52055fig5.jpg" /> Figura 5. INR (HBD n = 5, DCD n = 10). Un valor alto indica INR función hepatocelular disminuida debido a la disminución de la liberación de factores de coagulación. En ambos grupos HBD y DCD, los valores de INR vuelvan a los valores normales de 5 días después del trasplante, lo que sugiere la recuperación de la función hepática. Los valores para el grupo de HBD aparecen inferior.

Watch this Scientific Journal Video about Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt at JoVE.com

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Experimental animal research plays a pivotal role in the development of clinical transplantation practice. The porcine orthotopic liver transplantation model (OLTx) closely resembles human conditions and is frequently used in clinically oriented research. The following protocol contains all information for a reliable porcine OLTx model using an active porto-caval-jugular shunt.

Técnica de Adquisiciones de hígado porcino y trasplante ortotópico usando un Active Porto-Caval derivación

The success of liver transplantation has resulted in a dramatic organ shortage. Each year, a considerable number of patients on the liver transplantation ...

technique-porcine-liver-procurement-orthotopic-transplantation-using

Universidad San Sebastian

Research

JoVE Journal

Medicine

16.3K vistas.  Toronto General Hospital. Experimental animal research plays a pivotal role in the development of clinical transplantation practice. The porcine orthotopic liver transplantation model (OLTx) closely resembles human conditions and is frequently used in clinically oriented research. The following protocol contains all information for a reliable porcine OLTx model using an active porto-caval-jugular shunt.

Video: Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Orthotopic Small Bowel Transplantation in Rats

Small bowel transplantation has become an accepted clinical option for patients with short gut syndrome and failure of parenteral nutrition (irreversible intestinal failure). In specialized centers improved operative and managing strategies have led to excellent short- and intermediate term patient and graft survival while providing high quality of life 1,3. Unlike in the more common transplantation of other solid organs (i.e. heart, liver) many underlying mechanisms of graft function and immunologic alterations induced by intestinal transplantation are not entirely known6,7. Episodes of acute rejection, sepsis and chronic graft failure are the main obstacles still contributing to less favorable long term outcome and hindering a more widespread employment of the procedure despite a growing number of patients on home parenteral nutrition who would potentially benefit from such a transplant. The small intestine contains a large number of passenger leucocytes commonly referred to as part of the gut associated lymphoid system (GALT) this being part of the reason for the high immunogenity of the intestinal graft. The presence and close proximity of many commensals and pathogens in the gut explains the severity of sepsis episodes once graft mucosal integrity is compromised (for example by rejection). To advance the field of intestinal- and multiorgan transplantation more data generated from reliable and feasible animal models is needed. The model provided herein combines both reliability and feasibility once established in a standardized manner and can provide valuable insight in the underlying complex molecular, cellular and functional mechanisms that are triggered by intestinal transplantation. We have successfully used and refined the described procedure over more than 5 years in our laboratory 8-11. The JoVE video-based format is especially useful to demonstrate the complex procedure and avoid initial pitfalls for groups planning to establish an orthotopic rodent model investigating intestinal transplantation.

Small bowel transplantation has become an accepted treatment option for patients with irreversible intestinal failure. Our experimental model of orthotopic small bowel transplantation in rats serves as a reliable tool to address underlying immunologic and inflammatory processes that complicate intestinal transplantation.

El trasplante ortotópico de intestino delgado en ratas

Small  bowel transplantation has become an accepted clinical option for patients with  short gut syndrome and failure of parenteral nutrition ...

Investigación

Medicina

Orthotopic Liver Transplantation in Rats

Clinical progress in the field of liver transplantation has been largely supported by animal models1,2. Since the publication of the first orthotopic rat liver transplantation in 1979 by Kamada et al.3, this model has remained the gold standard despite various proposed alternative techniques4. Nevertheless, its broader use is limited by its steep learning curve5.
In this video paper, we show a simple and easy-to-establish revision of Kamada's two-cuff technique. The suprahepatic vena cava anastomosis is performed manually with a running suture, and the vena porta and infrahepatic vena cava anastomoses are performed utilizing a quick-linker cuff system6. Manufacturing the quick-linker kit is shown in a separate video paper.

We present an easy-to-establish revision of the classical two-cuff technique for orthotopic liver transplantation in rat.

Trasplante ortotópico de hígado en ratas

Clinical progress in the field of liver transplantation has been largely supported by animal models1,2. Since the publication of the first orthotopic rat ...

Surgical Procedures for a Rat Model of Partial Orthotopic Liver Transplantation with Hepatic Arterial Reconstruction

Orthotopic liver transplantation (OLT) in rats using a whole or partial graft is an indispensable experimental model for transplantation research, such as studies on graft preservation and ischemia-reperfusion injury 1,2, immunological responses 3,4, hemodynamics 5,6, and small-for-size syndrome 7. The rat OLT is among the most difficult animal models in experimental surgery and demands advanced microsurgical skills that take a long time to learn. Consequently, the use of this model has been limited. Since the reliability and reproducibility of results are key components of the experiments in which such complex animal models are used, it is essential for surgeons who are involved in rat OLT to be trained in well-standardized and sophisticated procedures for this model.
While various techniques and modifications of OLT in rats have been reported 8 since the first model was described by Lee et al. 9 in 1973, the elimination of the hepatic arterial reconstruction 10 and the introduction of the cuff anastomosis technique by Kamada et al. 11 were a major advancement in this model, because they simplified the reconstruction procedures to a great degree. In the model by Kamada et al., the hepatic rearterialization was also eliminated. Since rats could survive without hepatic arterial flow after liver transplantation, there was considerable controversy over the value of hepatic arterialization. However, the physiological superiority of the arterialized model has been increasingly acknowledged, especially in terms of preserving the bile duct system 8,12 and the liver integrity 8,13,14.
In this article, we present detailed surgical procedures for a rat model of OLT with hepatic arterial reconstruction using a 50% partial graft after ex vivo liver resection. The reconstruction procedures for each vessel and the bile duct are performed by the following methods: a 7-0 polypropylene continuous suture for the supra- and infrahepatic vena cava; a cuff technique for the portal vein; and a stent technique for the hepatic artery and the bile duct.

Orthotopic liver transplantation in rats is an indispensable experimental model for biomedical research. Here we present our surgical procedures for orthotopic rat liver transplantation with hepatic arterial reconstruction using a 50% partial graft.

Procedimientos Quirúrgicos para un modelo de rata de trasplante hepático ortotópico parcial con reconstrucción arterial hepática

Orthotopic liver transplantation (OLT) in rats using a whole or partial graft is an indispensable experimental model for transplantation research, such as ...

Orthotopic Hind Limb Transplantation in the Mouse

In vivo animal model systems, and in particular mouse models, have evolved into powerful and versatile scientific tools indispensable to basic and translational research in the field of transplantation medicine. A vast array of reagents is available exclusively in this setting, including mono- and polyclonal antibodies for both diagnostic and interventional applications. In addition, a vast number of genotyped, inbred, transgenic, and knock out strains allow detailed investigation of the individual contributions of humoral and cellular components to the complex interplay of an immune response and make the mouse the gold standard for immunological research. 
Vascularized Composite Allotransplantation (VCA) delineates a novel field of transplantation using allografts to replace "like with like" in patients suffering traumatic or congenital tissue loss. This surgical methodological protocol shows the use of a non-suture cuff technique for super-microvascular anastomosis in an orthotopic mouse hind limb transplantation model. The model specifically allows for comparison between established paradigms in solid organ transplantation with a novel form of transplants consisting of various different tissue components. Uniquely, this model allows for the transplantation of a viable vascularized bone marrow compartment and niche that have the potential to exert a beneficial effect on the balance of immune acceptance and rejection. This technique provides a tool to investigate alloantigen recognition and allograft rejection and acceptance, as well as enables the pursuit of functional nerve regeneration studies to further advance this novel field of transplantation.

This novel model for orthotopic hind limb transplantation in the mouse, applying a non-suture cuff technique for super-microvascular anastomosis, provides a powerful tool for in&#160;vivo mechanistic immunological research related to vascularized composite allotransplantation (VCA).

Ortotópico de la extremidad posterior de trasplante en el ratón

In vivo animal model systems, and in particular mouse models, have evolved into powerful and versatile scientific tools indispensable to basic and ...

Using the Sleeve Technique in a Mouse Model of Aortic Transplantation - An Instructional Video

Orthotopic aortic transplantation using the sleeve technique reduces injury to the aorta with failure rate of only 10-20%. The time to anastomose the aorta in mice using the sleeve method was short and easy averaging 20 min, permitting studies of iso/allo grafts. The following article describes the aortic transplantation procedure used in our laboratory. The mice were anesthetized with a mixture of 1.5% volume isoflurane and 100% oxygen through a face mask. At this point, the segment of the aorta between the renal arteries and its bifurcation was separated from the vena cava, freely prepared and clampedat the proximal and distal segments with a single silk suture. Prior to the removal of the aorta, a saline solution containing heparin was injected into the inferior vena cava. Then the aorta was cut between the clamps and a saline heparin solution was used to flush the lumen. The sleeve technique with monofilament sutures was used in order to transplant the abdominal aorta in the orthotopic position.

We present an orthotopic aortic transplantation model using the sleeve technique in mice. It is a very rapid anastomosis method, which can be employed in studies of vascular disease.

Utilizando la técnica de la manga en un modelo murino de trasplante aórtico - un Video instructivo

Orthotopic aortic transplantation using the sleeve technique reduces injury to the aorta with failure rate of only 10-20%. The time to anastomose the ...

A Rat Model of Orthotopic Liver Transplantation Using a Novel Magnetic Anastomosis Technique for Suprahepatic Vena Cava Reconstruction

The rat model of orthotopic liver transplantation (OLT) is essential for transplant research. It is a very sophisticated animal model and requires a steep learning curve. The introduction of the cuff technique for anastomosis of the portal vein (PV) and infrahepatic vena cava (IHVC) has significantly simplified the transplant procedure in rats. However, due to the short anterior wall of the recipients' suprahepatic vena cava (SHVC), the cuff technique is very difficult to use for the reconstruction of the SHVC. Most researchers in this field still use the hand-suture technique for SHVC reconstruction, which makes it the bottleneck step in rat orthotopic liver transplantation. The magnetic anastomosis technique (i.e., magnamosis) is a method of connecting two vessels using the attractive force between two magnets. Our recent study has shown that the magnetic anastomosis technique is superior to the hand-suture technique for SHVC reconstruction in rats. In this article, we show a step-by-step protocol for SHVC reconstruction in rats using the novel magnetic anastomosis technique. In this model, the reconstruction of the PV and IHVC was performed by the standard cuff technique, while the reconstruction of the bile duct (BD) was performed by a stent technique. The hepatic re-arterialization was not performed. The magnetic anastomosis technique made SHVC reconstruction much easier and significantly shortened the anphepatic phase. After a reasonable learning curve, even researchers without advanced microsurgical skills can produce reliable and reproducible results using this rat model of OLT.

The reconstruction of the suprahepatic vena cava (SHVC) remains a difficult step in rat orthotopic liver transplantation. In this article, we show a step-by-step protocol for SHVC reconstruction in rats using a novel magnetic anastomosis technique.

Un modelo de rata de Orthotopic trasplante del hígado usando una técnica de Anastomosis magnética novela para la reconstrucción de la Vena Cava suprahepática

The rat model of orthotopic liver transplantation (OLT) is essential for transplant research. It is a very sophisticated animal model and requires a steep ...

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

Fifty-years following the first successful report, cardiac transplantation remains the gold-standard treatment for eligible patients with advanced heart failure. Multiple small-animal models of heart transplantation have been used to study the acute and long-term effects of novel therapies. However, few are tested and demonstrated success in clinical trials. It is of critical importance to evaluate new therapies in a clinically relevant large-animal model for efficient and reliable translation of basic studies&#39;&#160;findings. Here, we describe a pre-clinical large-animal (porcine) model of orthotopic heart transplantation that has been firmly established and previously used to investigate novel cardioprotective strategies. This procedure focuses on acute ischemia-reperfusion injury and is a reliable method to investigate novel interventions which have been tested and validated in smaller experimental models, such as the murine model. We demonstrate its usefulness in assessing cardiac performance during the early post-transplantation period and other potential possibilities enabled by the model.

Here, we describe a pre-clinical large-animal (porcine) model of orthotopic heart transplantation that has been firmly established and utilized to investigate novel cardioprotective strategies.

Un modelo preclínico porcino de trasplante ortotópico de corazón

Fifty-years following the first successful report, cardiac transplantation remains the gold-standard treatment for eligible patients with advanced heart ...

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

The rat orthotopic liver transplantation (OLT) model is a powerful tool to study acute and chronic rejection. However, it is not a complete representation of human liver transplantation due to the absence of arterial reconnection. Described here is a modified transplantation procedure that includes the incorporation of hepatic artery (HA) reconnection, leading to a marked improvement in transplant outcomes. With a mean anhepatic time of 12 min and 14 s, HA reconnection results in improved perfusion of the transplanted liver and an increase in long-term recipient survival from 37.5% to 88.2%. This protocol includes the use of 3D-printed cuffs and holders to connect the portal vein and infrahepatic inferior vena cava. It can be implemented for studying multiple aspects of liver transplantation, from immune response and infection to technical aspects of the procedure. By incorporating a simple and practical method for arterial reconnection using a microvascular technique, this modified rat OLT protocol closely mimics aspects of human liver transplantation and will serve as a valuable and clinically relevant research model.

The goal of this study is to modify the rat orthotopic liver transplant model to better represent human liver transplantation and improve recipient survival. The presented method reestablishes hepatic arterial inflow by connecting the donor liver&#39;s common hepatic artery to the recipient liver&#39;s proper hepatic artery.

Reducción de las complicaciones después de la reconexión arterial en un modelo de rata de trasplante hepático ortotópico

The rat orthotopic liver transplantation (OLT) model is a powerful tool to study acute and chronic rejection. However, it is not a complete representation ...

Orthotopic Kidney Auto-Transplantation in a Porcine Model Using 24 Hours Organ Preservation And Continuous Telemetry

In the present era of organ transplantation with critical organ shortage, various strategies are employed to expand the pool of available allografts for kidney transplantation (KT). Even though, the use of allografts from extended criteria donors (ECD) could partially ease the shortage of organ donors, ECD organs carry a potentially higher risk for inferior outcomes and postoperative complications. Dynamic organ preservation techniques, modulation of ischemia-reperfusion and preservation injury, and allograft therapies are in the spotlight of scientific interest in an effort to improve allograft utilization and patient outcomes in KT.
Preclinical animal experiments are playing an essential role in translational research, especially in the medical device and drug development. The major advantage of the porcine orthotopic auto-transplantation model over ex vivo or small animal studies lies within the surgical-anatomical and physiological similarities to the clinical setting. This allows the investigation of new therapeutic methods and techniques and ensures a facilitated clinical translation of the findings. This protocol provides a comprehensive and problem-oriented description of the porcine orthotopic kidney auto-transplantation model, using a preservation time of 24 hours and telemetry monitoring. The combination of sophisticated surgical techniques with highly standardized and state-of-the-art methods of anesthesia, animal housing, perioperative follow up, and monitoring ensure the reproducibility and success of this model.

Large animal models play an essential role in preclinical transplantation research. Due to its similarities to the clinical setup, the porcine model of orthotopic kidney auto-transplantation described in this article provides an excellent in vivo setting for the testing of organ preservation techniques and therapeutic interventions.

Autoaplano de riñón ortotópico en un modelo porcino utilizando 24 horas de preservación de órganos y telemetría continua

In the present era of organ transplantation with critical organ shortage, various strategies are employed to expand the pool of available allografts for ...

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP

Lung transplantation is the gold-standard treatment for end-stage lung disease, with over 4,600 lung transplantations performed worldwide annually. However, lung transplantation is limited by a shortage of available donor organs. As such, there is high waitlist mortality. Ex situ lung perfusion (ESLP) has increased donor lung utilization rates in some centers by 15%-20%. ESLP has been applied as a method to assess and recondition marginal donor lungs and has demonstrated acceptable short- and long-term outcomes following transplantation of extended criteria donor (ECD) lungs. Large animal (in vivo) transplantation models are required to validate ongoing in vitro research findings. Anatomic and physiologic differences between humans and pigs pose significant technical and anesthetic challenges. An easily reproducible transplant model would permit the&#160;in vivo&#160;validation of current ESLP strategies and the preclinical evaluation of various interventions designed to improve donor lung function. This protocol describes a porcine model of orthotopic left lung allotransplantation. This includes anesthetic and surgical techniques, a customized surgical checklist, troubleshooting, modifications, and the benefits and limitations of the approach.

This protocol describes a juvenile porcine model of orthotopic left lung allotransplantation designed for use with ESLP research. Focus is made on anesthetic and surgical techniques, as well as critical steps and troubleshooting.

Trasplante ortotópico de pulmón izquierdo en un modelo porcino juvenil para LESP

Lung transplantation is the gold-standard treatment for end-stage lung disease, with over 4,600 lung transplantations performed worldwide annually. ...